Blume Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-100
| Closed | -$6.91K | – | 318 |
|
|
2024
Q1 | $6.91K | Sell |
100
-110
| -52% | -$7.6K | ﹤0.01% | 263 |
|
|
2023
Q4 | $15.5K | Hold |
210
| – | – | ﹤0.01% | 227 |
|
|
2023
Q3 | $14.3K | Hold |
210
| – | – | ﹤0.01% | 230 |
|
|
2023
Q2 | $19.7K | Hold |
210
| – | – | 0.01% | 214 |
|
|
2023
Q1 | $14.2K | Hold |
210
| – | – | ﹤0.01% | 225 |
|
|
2022
Q4 | $10.4K | Hold |
210
| – | – | ﹤0.01% | 246 |
|
|
2022
Q3 | $7K | Hold |
210
| – | – | ﹤0.01% | 258 |
|
|
2022
Q2 | $8K | Hold |
210
| – | – | ﹤0.01% | 257 |
|
|
2022
Q1 | $15K | Hold |
210
| – | – | ﹤0.01% | 233 |
|
|
2021
Q4 | $16K | Hold |
210
| – | – | 0.01% | 229 |
|
|
2021
Q3 | $20K | Hold |
210
| – | – | 0.01% | 230 |
|
|
2021
Q2 | $26K | Hold |
210
| – | – | 0.01% | 204 |
|
|
2021
Q1 | $28K | Hold |
210
| – | – | 0.01% | 186 |
|
|
2020
Q4 | $28K | Hold |
210
| – | – | 0.01% | 144 |
|
|
2020
Q3 | $21K | Hold |
210
| – | – | 0.01% | 150 |
|
|
2020
Q2 | $18K | Hold |
210
| – | – | 0.01% | 149 |
|
|
2020
Q1 | $12K | Hold |
210
| – | – | 0.01% | 169 |
|
|
2019
Q4 | $19K | Hold |
210
| – | – | 0.01% | 161 |
|
|
2019
Q3 | $18K | Buy |
+210
| New | +$18K | 0.01% | 163 |
|
|
2019
Q2 | – | Sell |
-210
| Closed | -$18K | – | 221 |
|
|
2019
Q1 | $18K | Buy |
+210
| New | +$18K | 0.01% | 165 |
|